The average P/S ratio for TECH's competitors is 6.16, providing a benchmark for relative valuation. Bio-Techne Corp Corp (TECH) exhibits a P/S ratio of 6.75, which is 9.56% above the industry average. Given its robust revenue growth of 4.20%, this premium appears unsustainable.